Platform
Features
0 followers
Rafael Holdings (NYSE: RFL) is focused on the development of novel cancer therapies. The Company is a significant investor in two clinical stage oncology companies-- Rafael Pharmaceuticals, Inc. and LipoMedix Pharmaceuticals Ltd.
Industries
Headquarters
Stage
Employees
Links
William Conkling
8 members
Neogene Therapeutics
2 followers
Othram
1 follower
Nuvalent
Thermo Fisher Scientific
140 followers
Genentech
142 followers
Gilead Sciences
119 followers
Biogen
107 followers
Regeneron
87 followers
Illumina
65 followers
Need
BeiGene
18 followers
Discover companies
